1. REFERENCES

2. Sabz G, Moradi S, Sharifi A, Naghmachi M, Sisakht MT, Khoramrooz SS. Identification and detection of pathogenic bacteria in adenoid tissue of adenoidectomized children: emergence of Staphylococcus aureus as the most prevalent pathogen. Jundishapur Journal of Microbiology 2020; 13(10): e106825.## [DOI:10.5812/jjm.95445]

3. Neela V, Ghasemzadeh Moghaddam H, van Belkum A, Horst-Kreft D, Mariana NS, Ghaznavi Rad E. First report on methicillin-resistant Staphylococcus aureus of Spa type T037, Sequence type 239, SCC mec type III/IIIA in Malaysia. European Journal of Clinical Microbiology & Infectious Diseases 2010; 29: 115-7. ## [DOI:10.1007/s10096-009-0813-6] [PMID] []

4. Shittu AO, Lin J. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infectious Diseases 2006; 6: 1-13. ## [DOI:10.1186/1471-2334-6-125] [PMID] []

5. Askarinia M, Ghaedi M, Manzouri L, Khoramrooz SS, Sharifi A, Ghalamfarsa G, et al. The Effect of Cu-BPDCA-Ty on Antibacterial Activity and The Expression of mecA Gene in Clinical and Standard Strains of Methicillin-Resistant Staphylococcus aureus. Jundishapur J Microbiol 2018; 11(3): e60680. ## [DOI:10.5812/jjm.60680]

6. Moridikia F, Ghaedi M, Khosravania SA, Khoramrooz SS, Mohseni R, Zoladl M, et al. The influence of hydro alcoholic extract of Satureja mutica zinc Oxide nanoparticle and zinc complex against coagulase gene expression on standard and clinical isolated of methicillin resistant staphylococcus aureus. Journal of Computational Applied Mechanics 2022; 53(1): 41-4. ##

7. Sutherland R. Pseudomonic acid, an antibiotic produced by Pseudomonas fluorescens. Proceedings of the 16th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1976. ##

8. Capobianco J, Doran C, Goldman R. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrobial Agents and Cchemotherapy 1989; 33(2): 156-63. ## [DOI:10.1128/AAC.33.2.156] [PMID] []

9. Wertheim HF, Melles DC, Vos MC, Van Leeuwen W, Van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious Diseases 2005; 5(12): 751-62. ## [DOI:10.1016/S1473-3099(05)70295-4] [PMID]

10. Simone-Finstrom M, Spivak M. Propolis and bee health: the natural history and significance of resin use by honey bees. Apidologie 2010; 41(3): 295-311. ## [DOI:10.1051/apido/2010016]

11. Gao SS, Hothersall J, Wu JE, Murphy AC, Song Z, Stephens ER, et al. Biosynthesis of mupirocin by Pseudomonas fluorescens NCIMB 10586 involves parallel pathways. Journal of the American Chemical Society 2014; 136(14): 5501-7. ## [DOI:10.1021/ja501731p] [PMID]

12. Thomas CM, Hothersall J, Willis CL, Simpson TJ. Resistance to and synthesis of the antibiotic mupirocin. Nature Reviews Microbiology 2010; 8(4): 281-9. ## [DOI:10.1038/nrmicro2278] [PMID]

13. Durai R, Ng PC, Hoque H. Methicillin-resistant Staphylococcus aureus: an update. AORN Journal 2010; 91(5): 599-609. ## [DOI:10.1016/j.aorn.2009.11.065] [PMID]

14. Rahman M, Noble W, Cookson B. Transmissible mupirocin resistance in Staphylococcus aureus. Epidemiology & Infection 1989; 102(2): 261-70. ## [DOI:10.1017/S0950268800029939] [PMID] []

15. Morton TM, Johnston JL, Patterson J, Archer GL. Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrobial Agents and Chemotherapy 1995; 39(6): 1272-80. ## [DOI:10.1128/AAC.39.6.1272] [PMID] []

16. Rahman M, Noble WC, Cookson B. Transmissible mupirocin resistance in Staphylococcus aureus. Epidemiology & Infection 1989; 102(2): 261-70. ## [DOI:10.1017/S0950268800029939] [PMID] []

17. Desroches M, Potier J, Laurent F, Bourrel AS, Doucet-Populaire F, Decousser JW, et al. Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus(MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA. Journal of Antimicrobial Chemotherapy 2013; 68(8): 1714-7. ## [DOI:10.1093/jac/dkt085] [PMID]

18. Chaves F, García-Martínez J, de Miguel S, Otero JR. Molecular characterization of resistance to mupirocin in methicillin-susceptible and-resistant isolates of Staphylococcus aureus from nasal samples. Journal of Clinical Microbiology 2004; 42(2): 822-4. ## [DOI:10.1128/JCM.42.2.822-824.2004] [PMID] []

19. Hogue JS, Buttke P, Braun LE, Fairchok MP. Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population. Journal of Clinical Microbiology 2010; 48(7): 2599-600. ## [DOI:10.1128/JCM.02118-09] [PMID] []

20. Hughes J, Stabler R, Gaunt M, Karadag T, Desai N, Betley J, et al. Clonal variation in high-and low-level phenotypic and genotypic mupirocin resistance of MRSA isolates in south-east London. Journal of Antimicrobial Chemotherapy 2015; 70(12): 3191-9. ## [DOI:10.1093/jac/dkv248] [PMID]

21. Henkel T, Finlay J. Emergence of resistance during mupirocin treatment: is it a problem in clinical practice? Journal of Chemotherapy 1999; 11(5): 331-7. ## [DOI:10.1179/joc.1999.11.5.331] [PMID]

22. Poovelikunnel T, Gethin G, Humphreys H. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. Journal of Antimicrobial Chemotherapy 2015; 70(10): 2681-92. ## [DOI:10.1093/jac/dkv169] [PMID]

23. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus(MRSA). Journal of Hospital Infection 1997; 35(1): 1-8. ## [DOI:10.1016/S0195-6701(97)90162-6] [PMID]

24. Decousser J, Pina P, Ghnassia J, Bedos J, Allouch P. First report of clinical and microbiological failure in the eradication of glycopeptide-intermediate methicillin-resistant Staphylococcus aureus carriage by mupirocin. European Journal of Clinical Microbiology and Infectious Diseases 2003; 22: 318-9. ## [DOI:10.1007/s10096-003-0929-z] [PMID]

25. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 2000; 31(6): 1380-5. ## [DOI:10.1086/317484] [PMID]

26. Antonio M, McFerran N, Pallen MJ. Mutations affecting the rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2002; 46(2): 438-42. ## [DOI:10.1128/AAC.46.2.438-442.2002] [PMID] []

27. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. The Journal of Antimicrobial Chemotherapy 1998; 41(1): 11-8. ## [DOI:10.1093/jac/41.1.11] [PMID]

28. Clewell DB, Francia MV. Conjugation in Gram‐positive bacteria. Plasmid biology. 2004: 227-56. [DOI:10.1128/9781555817732.ch10]

29. Zhu W, Clark N, Patel JB. pSK41-like plasmid is necessary for Inc18-like vanA plasmid transfer from Enterococcus faecalis to Staphylococcus aureus in vitro. Antimicrobial Agents and Chemotherapy 2013; 57(1): 212-9. ## [DOI:10.1128/AAC.01587-12] [PMID] []

30. Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. Modes and modulations of antibiotic resistance gene expression. Clinical Microbiology Reviews 2007; 20(1): 79-114. ## [DOI:10.1128/CMR.00015-06] [PMID] []

31. Dupeyron C, Campillo B, Richardet JP, Soussy CJ. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit. Journal of Hospital Infection 2006; 63(4): 385-92. ## [DOI:10.1016/j.jhin.2006.03.019] [PMID]

32. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. New England Journal of Medicine 2002; 346(24): 1871-7. ## [DOI:10.1056/NEJMoa003069] [PMID]

33. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clinical Infectious Diseases 2009; 48(7): 922-30. ## [DOI:10.1086/597291] [PMID]

34. Wertheim HF, Verveer J, Boelens HA, van Belkum A, Verbrugh HA, Vos MC. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrobial Agents and Chemotherapy 2005; 49(4): 1465-7. ## [DOI:10.1128/AAC.49.4.1465-1467.2005] [PMID] []

35. Roghmann MC, Lydecker AD, Shardell M, DeBoy RT, Johnson JK, Zhao L, et al. Effect of mupirocin for Staphylococcus aureus decolonization on the microbiome of the nose and throat in community and nursing home dwelling adults. PloS One 2021; 16(6): e0252004. ## [DOI:10.1371/journal.pone.0252004] [PMID] []

36. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infection Control & Hospital Epidemiology 2005; 26(12): 916-22. ## [DOI:10.1086/505453] [PMID]

37. Allegranzi B, Bischoff P, de Jonge S, Kubilay NZ, Zayed B, Gomes SM, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. The Lancet Infectious Diseases 2016; 16(12): e276-e87. ## [DOI:10.1016/S1473-3099(16)30398-X] [PMID]

38. Kalmeijer M, Coertjens H, Van Nieuwland-Bollen P, Bogaers-Hofman D, de Baere GJ, Stuurman A, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clinical Infectious Diseases 2002; 35(4): 353-8. ## [DOI:10.1086/341025] [PMID]

39. Alian S, Valedsaravi TS, Ahangarkani F, Davoudi A, Najafi N, Arabi M. Effect of intranasal mupirocin in preventing post-operative infection after open heart surgery. Journal of Mazandaran University of Medical Sciences 2019; 29(180): 46-56. ##

40. Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. Bmj 2013 33(3): 13; 346. ## [DOI:10.1136/bmj.f2743] [PMID] []

41. Levy PY, Ollivier M, Drancourt M, Raoult D, Argenson JN. Relation between nasal carriage of Staphylococcus aureus and surgical site infection in orthopedic surgery: the role of nasal contamination. A systematic literature review and meta-analysis. Orthopaedics & Traumatology: Surgery & Research 2013; 99(6): 645-51. ## [DOI:10.1016/j.otsr.2013.03.030] [PMID]

42. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clinical Infectious Diseases 2003; 37(12): 1629-38. ## [DOI:10.1086/379715] [PMID]

43. Nair R, Perencevich EN, Blevins AE, Goto M, Nelson RE, Schweizer ML. Clinical effectiveness of mupirocin for preventing Staphylococcus aureus infections in nonsurgical settings: a meta-analysis. Clinical Infectious Diseases 2016; 62(5): 618-30. ## [DOI:10.1093/cid/civ901] [PMID]

44. Creech CB, Al-Zubeidi DN, Fritz SA. Prevention of recurrent staphylococcal skin infections. Infectious Disease Clinics 2015; 29(3): 429-64. ## [DOI:10.1016/j.idc.2015.05.007] [PMID] []

45. Breneman DL. Use of mupirocin ointment in the treatment of secondarily infected dermatoses. Journal of the American Academy of Dermatology 1990; 22(5): 886-92. ## [DOI:10.1016/0190-9622(90)70119-3] [PMID]

46. Mascitti KB, Gerber JS, Zaoutis TE, Barton TD, Lautenbach E. Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers. American Journal of Infection Control 2010; 38(4): 324-8. ## [DOI:10.1016/j.ajic.2009.11.007] [PMID] []

47. Ghiselli R, Giacometti A, Goffi L, Cirioni O, Mocchegiani F, Orlando F, et al. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed Dacron. Journal of Surgical Research 2001; 99(2): 316-20. ## [DOI:10.1006/jsre.2001.6138] [PMID]

48. Climo MW, Patron RL, Archer GL. Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrobial Agents and Chemotherapy 1999; 43(7): 1747-53. ## [DOI:10.1128/AAC.43.7.1747] [PMID] []

49. Alou L, Cafini F, Sevillano D, Unzueta I, Prieto J. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin. International Journal of Antimicrobial Agents 2004; 23(5): 513-6. ## [DOI:10.1016/j.ijantimicag.2003.09.030] [PMID]

50. Blanchard C, Brooks L, Beckley A, Colquhoun J, Dewhurst S, Dunman PM. Neomycin sulfate improves the antimicrobial activity of mupirocin-based antibacterial ointments. Antimicrobial Agents and Chemotherapy 2016; 60(2): 862-72. ## [DOI:10.1128/AAC.02083-15] [PMID] []

51. Jones RN, Li Q, Kohut B, Biedenbach DJ, Bell J, Turnidge JD. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia. Diagnostic Microbiology and Infectious Disease 2006; 54(1): 63-71. ## [DOI:10.1016/j.diagmicrobio.2005.08.009] [PMID]

52. Ahire K, Wadile R, Pande B, Shejwal D. Mupirocin resistance patterns in staphylococcus isolates causing cutaneous and soft-tissue infections: An epidemiological study in a tertiary health-care facility, Dhule, Maharashtra, India. Asian Journal of Medical Sciences 2023; 14(11): 195-201. ## [DOI:10.3126/ajms.v14i11.57768]

53. Goudarzi M, Fazeli M, Eslami G, Pouriran R. Genetic diversity analysis of mupirocin-resistant Staphylococcus aureus clinical isolates in Tehran hospitals, Iran. Microbial Drug Resistance 2019; 25(4): 558-66. ## [DOI:10.1089/mdr.2018.0146] [PMID]

54. Kumar D, Bisht D, Faujdar SS. Incidence of mupirocin resistance in Staphylococcus aureus isolated from rural population: A new emerging challenge. Int J Cur Res Rev 2020; 12(22): 82-5. ## [DOI:10.31782/IJCRR.2020.12225]

55. Chen S, Jin Y, Lin C, Hao Z, Duan J, Guo Y, et al. Low prevalence of mupirocin resistance among Staphylococcus aureus clinical isolates from a Chinese tertiary hospital. Journal of Medical Microbiology 2019; 68(2): 201-5. ## [DOI:10.1099/jmm.0.000911] [PMID]

56. Khoshnood S, Heidary M, Asadi A, Soleimani S, Motahar M, Savari M, et al. A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomedicine & Pharmacotherapy 2019; 109: 1809-18. ## [DOI:10.1016/j.biopha.2018.10.131] [PMID]

57. Lee A, Macedo-Vinas M, Francois P, Renzi G, Vernaz N, Schrenzel J, et al. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. Journal of Hospital Infection 2011; 77(4): 360-2. ## [DOI:10.1016/j.jhin.2010.11.002] [PMID]

58. Mehrishi P, Faujdar SS, Kumar S, Solanki S, Sharma A. Antibiotic susceptibility profile of uropathogens in rural population of Himachal Pradesh, India: Where We are heading? Biomedical and Biotechnology Research Journal(BBRJ) 2019; 3(3): 171-5. ## [DOI:10.4103/bbrj.bbrj_102_19]

59. Doudoulakakis A, Spiliopoulou I, Spyridis N, Giormezis N, Kopsidas J, Militsopoulou M, et al. Emergence of a Staphylococcus aureus clone resistant to mupirocin and fusidic acid carrying exotoxin genes and causing mainly skin infections. Journal of Clinical Microbiology 2017; 55(8): 2529-37. ## [DOI:10.1128/JCM.00406-17] [PMID] []

60. Fritz SA, Hogan PG, Camins BC, Ainsworth AJ, Patrick C, Martin MS, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrobial Agents and Chemotherapy 2013; 57(1): 559-68. ## [DOI:10.1128/AAC.01633-12] [PMID] []

61. Shittu AO, Udo EE, Lin J. Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low-and high-level mupirocin resistance in Nigeria and South Africa. BMC Infectious Diseases 2009; 9: 1-9. ## [DOI:10.1186/1471-2334-9-10] [PMID] []

62. Orrett FA. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Japanese Journal of Infectious Diseases 2008; 61(2): 107-10. ## [DOI:10.7883/yoken.JJID.2008.107] [PMID]

63. Abdulgader SM, Shittu AO, Nicol MP, Kaba M. Molecular epidemiology of methicillin-resistant staphylococcus aureus in africa: a systematic review. Frontiers in Microbiology 2015; 6: 140419. ## [DOI:10.3389/fmicb.2015.00348] [PMID] []

64. Vasquez JE, Walker ES, Franzus BW, Overbay BK, Reagan DR, Sarubbi FA. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infection Control & Hospital Epidemiology 2000; 21(7): 459-64. ## [DOI:10.1086/501788] [PMID]

65. Simor AE, Stuart TL, Louie L, Watt C, Ofner-Agostini M, Gravel D, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrobial Agents and Chemotherapy 2007; 51(11): 3880-6. ## [DOI:10.1128/AAC.00846-07] [PMID] []

66. Antonov NK, Garzon MC, Morel KD, Whittier S, Planet PJ, Lauren CT. High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population. Antimicrobial Agents and Chemotherapy 2015; 59(6): 3350-6. ## [DOI:10.1128/AAC.00079-15] [PMID] []

67. Jones JC, Rogers TJ, Brookmeyer P, Dunne Jr WM, Storch GA, Coopersmith CM, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clinical Infectious Diseases 2007; 45(5): 541-7. ## [DOI:10.1086/520663] [PMID]

68. Nezhad RR, Meybodi SM, Rezaee R, Goudarzi M, Fazeli M. Molecular characterization and resistance profile of methicillin resistant Staphylococcus aureus strains isolated from hospitalized patients in intensive care unit, Tehran-Iran. Jundishapur Journal of Microbiology. 2017; 10(3): 1. ## [DOI:10.5812/jjm.41666]

69. Nikfar G, Jamali H, Ahmadzadagan J. Simultaneous detection of methicillin-and mupirocin-resistant genes in Staphylococcus aureus isolated with multiplex PCR from patients in the city of Darab, Fars Province, Iran. Int J Med Res Heal Sci 2016; 5: 125-31. ##

70. Prakash R, Garg A, Arya R, Kumawat R. Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals. Scientific Reports 2023; 13(1): 10171. ## [DOI:10.1038/s41598-023-37399-0] [PMID] []

71. Joshi PR, Acharya M, Aryal R, Thapa K, Kakshapati T, Seng R, et al. Emergence of staphylococcal cassette chromosome mec type I with high-level mupirocin resistance among methicillin-resistant Staphylococcus aureus. Asian Pacific Journal of Tropical Biomedicine 2017; 7(3): 193-7. ## [DOI:10.1016/j.apjtb.2016.12.002]

72. Ho PL, Liu MCJ, Chow KH, Tse CWS, Lo WU, Mak SK, et al. Emergence of ileS2-carrying, multidrug-resistant plasmids in Staphylococcus lugdunensis. Antimicrobial Agents and Chemotherapy 2016; 60(10): 6411-4. ## [DOI:10.1128/AAC.00948-16] [PMID] []

73. Mutu E, Chen G, Liu R, Wang Y. High prevalence of heterogeneous mupirocin-resistant Staphylococcus aureus and its molecular characterization. American Journal of Translational Research 2022; 14(11): 8243. ##

74. Barakat GI, Nabil YM. Correlation of mupirocin resistance with biofilm production in methicillin-resistant Staphylococcus aureus from surgical site infections in a tertiary centre, Egypt. Journal of Global Antimicrobial Resistance 2016; 4: 16-20. ## [DOI:10.1016/j.jgar.2015.11.010] [PMID]

75. Abdulgader SM, Lentswe T, Whitelaw A, Newton-Foot M. The prevalence and molecular mechanisms of mupirocin resistance in Staphylococcus aureus isolates from a Hospital in Cape Town, South Africa. Antimicrobial Resistance & Infection Control 2020; 9: 1-7. ## [DOI:10.1186/s13756-020-00707-8] [PMID] []

76. Warren DK, Prager M, Munigala S, Wallace MA, Kennedy CR, Bommarito KM, et al. Prevalence of qacA/B genes and mupirocin resistance among methicillin-resistant Staphylococcus aureus (MRSA) isolates in the setting of chlorhexidine bathing without mupirocin. Infection Control & Hospital Epidemiology 2016; 37(5): 590-7. ## [DOI:10.1017/ice.2016.1] [PMID] []

77. González-Domínguez M, Seral C, Potel C, Constenla L, Algarate S, Gude MJ, et al. Antimicrobial resistance, virulence factors and genetic lineages of hospital-onset methicillin-resistant Staphylococcus aureus isolates detected in a hospital in Zaragoza. Enfermedades Infecciosas Y Microbiologia Clinica 2015; 33(9): 590-6. ## [DOI:10.1016/j.eimc.2015.01.015] [PMID]

78. Mahmoodzadeh Hosseini H, Kiyani N, Amin M, Hedayati Ch M, Imani Fooladi AA. Distribution of high-level mupirocin resistance among clinical MRSA. Journal of Chemotherapy 2017; 29(4): 215-9. ## [DOI:10.1080/1120009X.2016.1201257] [PMID]

79. Dadashi M, Hajikhani B, Darban-Sarokhalil D, van Belkum A, Goudarzi M. Mupirocin resistance in Staphylococcus aureus: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 2020; 20: 238-47. ## [DOI:10.1016/j.jgar.2019.07.032] [PMID]

80. Jones JC, Rogers TJ, Brookmeyer P, Dunne Jr WM, Storch GA, Coopersmith CM, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clinical Infectious Diseases 2007; 45(5): 541-7 [DOI:10.1086/520663] [PMID]